Hematology and Medical Oncology Grand Rounds
September - June (on hiatus during summer months)
Grand Rounds: 1st Tuesday of the month
Fellows Conference: 3rd Tuesday of the month
8:00AM - 9:00AM (in person HSRF 200)
The Hematology/Oncology conferences listed on this page are not open to the general public.
Upcoming Grand Rounds
Recent Conferences
Academic Year 2024-2025
For prior years Grand Rounds schedule please contact Whitney Feininger
| Speaker | Presentation |
|---|---|
| "How I avoid overtreating myeloma: Musings of a west coast myeloma doctor"
|
| Dr. Jonathan Boyson, UVM | "Emerging roles of gamma delta T cells in cancer"
|
| Dr. Elizabeth Buchbinder, Dana Farber Cancer Institute | "What's new in melanoma and what we do when standard therapies fail"
|
| Dr. Marco Ruella, University of Pennsylvania | "Catch me if you can: Resistance to CART immunotherapy"
|
Dr. Adam Cuker, University of Pennsylvania
| "Diagnosis and Management of Heparin-Induced Thrombocytopenia: An updated based on the ASH Guidelines"
|
Dr. Douglas Sborov, Huntsman Cancer Institute, University of Utah
| "The New Frontier of Multiple Myeloma" |
Dr. Jennifer Kelly, UVMMC Department of Endocrinology
| "Bone health management in patients undergoing treatment for malignancy" |
Dr. Ryan Thomas, 3rd Year Fellow in Hematology and Medical Oncology, UVMMC
| Morbidity and Mortality Conference |
Dr. Maija Reblin, UVM Health Promotion/UVM Cancer Center
| "Caregiver Needs in Vermont" |
Dr. Elsy Rivera, 1st Year Fellow in Hematology and Medical Oncology
| "Anticoagulant & Antithrombotic Herbs" |
Dr. Rahul Vedula, Dana Farber Cancer Institute
| "CRISPR-based rapid diagnostics for fusion driven leukemias" |
Dr. Jinah Kim, 2nd Year Fellow in Hematology and Medical Oncology
| "The immunotherapy in early triple-negative breast cancer" |
Dr. Haze Xu. 3rd Year Fellow in Hematology and Medical Oncology
| "Rethinking the Obesity Paradox: Immune Checkpoint Inhibitor and The New Frontier" |
| "Parenthood on Ice: Safeguarding Reproductive Potential During Gonadotoxic Therapy" |
Dr. Dermot Murphy, 1st Year Fellow in Hematology and Medical Oncology, UVM Health and Dr. Ann Kim, Hematology and Oncology Fellow, Beth Israel Deaconess Medical Center
| Morbidity and Mortality Conference |
| Dr. Shruti Khurana, UVM LCOM Gastroenterology and Hepatology/Chron's and Colitis Clinic, UVM Medical Center | Immune Checkpoint Inhibitor Colitis |
| Dr. Ike Chidobem, 2nd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukemia (CLL) |
| Dr. Ryan Thomas, 3rd Year Fellow in Hematology and Medical Oncology, UVM Health Network | Quality Improvement Projects |
| Dr. Jacqueline Poston, UVM Department of Pathology and Laboratory Medicine | Revolutionizing Care: The Management of Acquired Hemophilia A in 2025 |